Glenmark Life Sciences Limited IPO Details

We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally. (Source: A Year of Surprises Shakes Up Off-Patent Industry” | Informa, 2020) With 120 APIs in our portfolio, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality. Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 540 pharma companies in multiple countries.

Glenmark Life Sciences Limited IPO Details
Issue Open	27-07-2021
Issue Close	29-07-2021
Allotment Date	03-08-2021
Unblocked Amount	04-08-2021
Credit Demat Amount	05-08-2021
Listing Date	06-08-2021
Issue Size	2,10,22,222 Total Equity Share 1,47,22,222 Fresh Issue Equity Share 63,00,000 OFS Equity Share
Issue Size	₹ 1513.60 Cr ₹ 1060.00 Cr Fresh ₹ 453.60 Cr OFS
IPO Price Band	₹ 695-720
Minimum Share Bid	20
Minimum Investment Amount [₹]	₹ 14,400
Face Value	₹ 2 Per equity share
Qualified Institutional Buyer [QIB]	50 %
High Networth Individual [HNI]	15 %
Retail Individual Investor [RII]	35 %
Listing On	BSE & NSE

Glenmark Life Sciences Limited IPO Grey Market Premium
Date	Offer Price	Premium	Kostak	Subject to Sauda	Listing Gain	Rating
21-07-2021	720	210	450	4500	6500	Apply
27-07-2021	720	150	-	-	3000	Apply
-	-	-	-	-	-	-

Glenmark Life Sciences Limited IPO Financial Details (₹ in Cr)
Financial Year	Total Asset	Total Revenue	Total Expenses	Profit After Tax
FY-2019	1475.4	1405.5	1001.66	293.115
FY-2020	1725.6	1549.3	1128.24	313.567
FY-2021	1997.08	1885.98	1415.03	351.055

Glenmark Life Sciences Limited IPO Valuation Details
Earnings Per Share [EPS]	₹ 32.61
Price/Earnings [P/E] Ratio	63.65
Return on Net Worth [RoNW]	46.71 %
Net Asset Value [NAV]	₹ 69.82 Per Share

Glenmark Life Sciences Limited IPO Subscription Details
As on Date	QIB	NII	RII	Total
Shared Offered	42,42,379	32,32,770	75,43,130	1,50,18,279
Day-1 [27-07-2021]	10,540 [0.0021]	27,64,440 [0.86]	3,90,04,280 [5.17]	4,17,79,260 [2.78]
Day-2 [28-07-2021]	58,65,480 [1.38]	1,09,69,980 [3.39]	6,99,72,180 [9,27]	8,68,07,640 [5.78]
Day-3 [29-07-2021]	15,68,29,300 [36.97]	39,61,29,640 [122.53]	11,03,65,220 [14.63]	66,33,24,160 [44.63]

Glenmark Life Sciences Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here

Glenmark Life Sciences Limited IPO Allotment Status
Check Allotment Status :- Click Here

Glenmark Life Sciences Limited IPO Live Subscription
Check Live Subscription in BSE:- Click Here to View Check Live Subscription in NSE:- Click Here to View

Download Glenmark Life Sciences Limited IPO DRHP & RHP
Download DRHP:- Click Here to Download Download RHP:- Click Here to Download

Glenmark Life Sciences Limited IPO Contact Details
Glenmark Life Sciences Limited 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East,  Mumbai– 400099, Maharashtra, India Tel: +91 2189 234456/ +91 2189 234246 Contact Person: Rudalf Corriea (Company Secretary and Compliance Officer); E-mail: complianceofficer@glenmarklifesciences.com Website: www.glenmarklifesciences.com Corporate Identity Number: U74900PN2011PLC139963

Registrar of Glenmark Life Sciences Limited IPO

KFin Technologies Private Limited (Formerly known as Karvy Fintech Private Limited) Selenium Tower-B Plot No-31 and 32, Financial District Nanakramguda, Serilingampally Hyderabad, Rangareddi 500032 Telangana, India Tel: +91 40 6716 2222 E-mail: glenmark.ipo@kfintech.com Investor Grievance E-mail: einward.ris@kfintech.com Website: www.kfintech.com Contact Person: M Murali Krishna SEBI Registration No.: INR000000221

Lead Managers of Glenmark Life Sciences Limited IPO

Kotak Mahindra Capital Company Limited 1st Floor, 27 BKC, Plot No. C - 27 ‘G’ Block, Bandra Kurla Complex Bandra (East), Mumbai 400 051 Maharashtra, India Tel: +91 22 4336 0000 E-mail: gls.ipo@kotak.com Investor grievance e-mail: kmccredressal@kotak.com Contact Person: Ganesh Rane Website: https://investmentbank.kotak.com SEBI Registration No: INM000008704 BofA Securities India Limited Ground Floor, “A” Wing, One BKC, “G” Block Bandra Kurla Complex, Bandra (East), Mumbai 400 051 Maharashtra, India Tel: +91 22 6632 8000 E-mail: dg.glenmark_ipo@bofa.com Investor Grievance E-mail: dg.india_merchantbanking@bofa.com Contact Person: Pritish Pani Website: www.ml-india.com SEBI Registration Number: INM000011625 Goldman Sachs (India) Securities Private Limited 951-A, Rational House, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025 Tel: +91 22 6616 9000 Email: glsipo@gs.com Investor Grievance Email: india-client-support@gs.com Contact Person: Chirag Jasani Website: www.goldmansachs.com SEBI Registration Number: MB/INM000011054 DAM Capital Advisors Limited (Formerly known as IDFC Securities Limited) One BKC, Tower C, 15th Floor Unit No. 1511, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051 Tel: +91 22 4202 2500 E-mail: glenmark.ipo@damcapital.in Investor grievance e-mail: complaint@damcapital.in Contact Person: Chandresh Sharma Website: www.damcapital.in SEBI Registration No.: MB/INM000011336 BOB Capital Markets Limited 1704, B Wing, 17th Floor Parinee Crescenzo Plot No. C - 38/39, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 Maharashtra, India Tel: +91 22 6138 9300 E-mail: gls.ipo@bobcaps.in Investor grievance ID: investorgrievance@bobcaps.in Contact Person: Ninad Jape Website: www.bobcaps.in SEBI Registration Number: INM000009926 SBI Capital Markets Limited 202, Maker Tower “E”, Cuffe Parade, Mumbai 400 005 Maharashtra,India Tel: +91 22 2217 8300 Email: gls.ipo@sbicaps.com Website: www.sbicaps.com Investor grievance e-mail: investor.relations@sbicaps.com Contact Person: Janardhan Wagle SEBI Registration No: INM000003531

Disclaimer:-

•       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO. •       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk •        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO. •       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.